Cybin (FRA:R7E1) Pre-Tax Income : €-48.41 Mil (TTM As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Cybin Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Cybin's pretax income for the three months ended in Dec. 2023 was €-20.73 Mil. Its pretax income for the trailing twelve months (TTM) ended in Dec. 2023 was €-48.41 Mil. Cybin's pretax margin was %.

During the past 4 years, Cybin's highest Pretax Margin was -3729.17%. The lowest was -3729.17%. And the median was -3729.17%.

Cybin Pre-Tax Income Historical Data

The historical data trend for Cybin's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cybin Pre-Tax Income Chart

Cybin Annual Data

Trend

Mar20

Mar21

Mar22

Mar23

Pre-Tax Income

-21.53

-48.51

-32.42

Cybin Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Pre-Tax Income	Get a 7-Day Free Trial										-7.46	-9.37	-10.08	-8.23	-20.73

Competitive Comparison of Cybin's Pre-Tax Income

For the Biotechnology subindustry, Cybin's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cybin's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cybin's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Cybin's Pre-Tax Income falls into.

Cybin Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Cybin's Pretax Income for the fiscal year that ended in Mar. 2023 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	-35.166	+	2.338	+	0	+	0.412	+	-0.0010000000000048
	=	-32.42

Cybin's Pretax Income for the quarter that ended in Dec. 2023 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	-18.471	+	-2.356	+	0	+	0.096	+	-3.5527136788005E-15
	=	-20.73

Pre-Tax Income for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €-48.41 Mil.

Cybin (FRA:R7E1) Pre-Tax Income Explanation

Cybin's Pretax Margin for the quarter that ended in Dec. 2023 is calculated as

Pretax Margin	=	Pretax Income	/	Revenue
	=	-20.731	/	0
	=	%

During the past 4 years, Cybin's highest Pretax Margin was -3729.17%. The lowest was -3729.17%. And the median was -3729.17%.

Cybin Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Cybin's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Cybin (FRA:R7E1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cybin Inc (FRA:R7E1) » Definitions » Pre-Tax Income

Comparable Companies

Traded in Other Exchanges

CYBN:USA CYBN:Canada

Address

100 King Street West, Suite 5600, Toronto, ON, CAN, M5X 1C9

Website

https://www.cybin.com

Cybin Inc is a biopharmaceutical company involved in creating safe and effective therapeutics for patients to address a multitude of mental health issues. The company is focused on advancing psychedelic-based therapies, delivery mechanisms, novel compounds and protocols as potential treatments for various psychiatric and neurological conditions.

Cybin (FRA:R7E1) Headlines

No Headlines